Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
186.13
-0.32 (-0.17%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Krystal Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 353.83 | 344.87 | 358.33 | 161.9 | 341.25 | 268.27 | Upgrade |
Short-Term Investments | 328.16 | 252.65 | 173.85 | 217.27 | 96.85 | 2.99 | Upgrade |
Cash & Short-Term Investments | 681.99 | 597.52 | 532.18 | 379.17 | 438.1 | 271.26 | Upgrade |
Cash Growth | 21.87% | 12.28% | 40.35% | -13.45% | 61.50% | 40.05% | Upgrade |
Receivables | 111.44 | 104.75 | 42.04 | - | - | - | Upgrade |
Inventory | 31.04 | 26.51 | 6.99 | - | - | - | Upgrade |
Prepaid Expenses | 16.88 | 13.27 | 6.71 | 4.61 | 4.17 | 3.8 | Upgrade |
Total Current Assets | 841.35 | 742.05 | 587.91 | 383.78 | 442.27 | 275.06 | Upgrade |
Property, Plant & Equipment | 158.04 | 161.45 | 168.23 | 169.73 | 119.58 | 34.17 | Upgrade |
Long-Term Investments | 138.81 | 152.11 | 61.95 | 4.62 | 64.37 | - | Upgrade |
Other Long-Term Assets | 0.2 | 0.23 | 0.26 | 0.32 | 0.07 | 1.61 | Upgrade |
Total Assets | 1,138 | 1,056 | 818.36 | 558.45 | 626.3 | 310.84 | Upgrade |
Accounts Payable | 7.12 | 4.99 | 4.13 | 3.98 | 8.4 | 2.11 | Upgrade |
Accrued Expenses | 66.65 | 52.78 | 18.15 | 11.54 | 6.52 | 3.99 | Upgrade |
Current Portion of Leases | 1.62 | 1.22 | 1.47 | 1.56 | 1.04 | 0.64 | Upgrade |
Current Income Taxes Payable | 8.3 | 4.29 | 1.96 | 0.04 | 0.08 | 0.04 | Upgrade |
Other Current Liabilities | 3.21 | 38.73 | 7.38 | 11.72 | 9.69 | 8.68 | Upgrade |
Total Current Liabilities | 86.9 | 102 | 33.09 | 28.85 | 25.74 | 15.45 | Upgrade |
Long-Term Leases | 8.06 | 6.04 | 6.62 | 7.37 | 6.98 | 3.31 | Upgrade |
Other Long-Term Liabilities | 2.79 | 1.42 | - | - | - | - | Upgrade |
Total Liabilities | 97.75 | 109.46 | 39.71 | 36.22 | 32.72 | 18.76 | Upgrade |
Additional Paid-In Capital | 1,146 | 1,127 | 1,048 | 803.72 | 734.52 | 363.29 | Upgrade |
Retained Earnings | -106.6 | -180.67 | -269.83 | -280.76 | -140.78 | -71.21 | Upgrade |
Comprehensive Income & Other | 1.16 | -0.19 | 0.64 | -0.73 | -0.16 | 0.01 | Upgrade |
Total Common Equity | 1,041 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade |
Shareholders' Equity | 1,041 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade |
Total Liabilities & Equity | 1,138 | 1,056 | 818.36 | 558.45 | 626.3 | 310.84 | Upgrade |
Total Debt | 9.68 | 7.26 | 8.09 | 8.93 | 8.02 | 3.95 | Upgrade |
Net Cash (Debt) | 811.11 | 742.37 | 586.04 | 374.86 | 494.44 | 267.32 | Upgrade |
Net Cash Growth | 30.57% | 26.68% | 56.34% | -24.19% | 84.97% | 40.38% | Upgrade |
Net Cash Per Share | 27.13 | 24.96 | 21.12 | 14.70 | 22.28 | 14.23 | Upgrade |
Filing Date Shares Outstanding | 28.94 | 28.81 | 28.29 | 25.76 | 25.21 | 22.19 | Upgrade |
Total Common Shares Outstanding | 28.93 | 28.79 | 28.24 | 25.76 | 25.21 | 19.71 | Upgrade |
Working Capital | 754.45 | 640.05 | 554.82 | 354.93 | 416.53 | 259.61 | Upgrade |
Book Value Per Share | 35.97 | 32.87 | 27.58 | 20.27 | 23.55 | 14.82 | Upgrade |
Tangible Book Value | 1,041 | 946.38 | 778.64 | 522.23 | 593.58 | 292.08 | Upgrade |
Tangible Book Value Per Share | 35.97 | 32.87 | 27.58 | 20.27 | 23.55 | 14.82 | Upgrade |
Buildings | 109.15 | 111.44 | 111.18 | - | - | - | Upgrade |
Machinery | 36.97 | 34.19 | 30.49 | 12.93 | 6.51 | 5.58 | Upgrade |
Construction In Progress | 3.44 | 5.78 | 7.29 | 131.33 | 104.34 | 23.03 | Upgrade |
Leasehold Improvements | 27.49 | 25.67 | 25.07 | 24.22 | 5.72 | 4.63 | Upgrade |
Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.